Purchase Order 75F40120P00267
Award Date 9/28/20
Potential Completion Date 10/28/20
Potential Value $249K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The United States Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grants Services has awarded a $605,098.90 firm fixed price purchase order to Molecular Devices LLC, a division of Danaher Corporation, to provide a High Content Screening System under solicitation FDA-RFQ-75F40123Q00015-CFSAN-2023-114792. The place of performance will be Molecular Devices LLC's facilities located in San Jose, California. The period of performance is from January 12,...
- The Food and Drug Administration awarded a $41,309.15 firm fixed price purchase order to Molecular Devices LLC for preventative maintenance and unlimited repair services on a Molecular Devices ImageXpress Micro Confocal High Content Imaging System. The contract, awarded July 1, 2024, with an ultimate completion date of June 30, 2025, was issued without a set-aside designation. Services will be performed at the National Center for Toxicological Research facility in Jefferson, Arkansas, and...
- This is a $190,019.00 firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA) and Center for Food Safety and Applied Nutrition (CFSAN) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for an on-site preventative maintenance service agreement for Molecular Devices' Image-Xpress Confocal HT.AI high-content screening system. The contract has an ultimate completion date of September 29, 2027. Molecular Devices is a for-profit limited...
- This is a firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Molecular Devices LLC for the provision of an ImageXpress Micro Confocal High Content Screening System. The $586,048.77 contract, which does not have a set-aside designation, has an ultimate completion date of May 15, 2017. Molecular Devices LLC, a division of Danaher Corporation, is a leading provider of bioanalytical measurement...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $287,976.64 firm fixed price purchase order to Molecular Devices, LLC for a BLI Detection System. As a prime contractor, Molecular Devices will deliver the requested detection system to support HHS FDA programs. Performance will occur at Molecular Devices' San Jose, California location from March 2020 through August 2020. No set aside designation or subcontractors were indicated. The award provides the...
- The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $3.86 million firm fixed price purchase order to Molecular Devices LLC for the acquisition of five Molecular Devices ImageXpress Confocal High-Content Imaging Systems, one FLIPR Penta high-throughput cellular screening system, along with associated software, services, consumables, installation, training, customization, maintenance, and technical support. The products and services are to support the...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $168,841.20 firm-fixed-price purchase order to Molecular Devices LLC, a subsidiary of Danaher Corporation, to provide an upgrade to the FLIPR Tetra high-throughput cellular screening system. This includes the installation of a high-speed electron multiplying charge-coupled device (HS-EMCCD) camera and associated Peak Pro 2 software. The upgrade will...
- This firm fixed price purchase order from the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to Molecular Devices LLC is valued at seventy-three thousand three hundred seventy-four dollars ($73,374) to upgrade an existing ImageXpress Micro Confocal High Content Imaging System (IXMC). The upgrade will include an automated water immersion unit and a 40x Apo LWD 1.15 NA water immersion objective, as requested in the combined synopsis and solicitation to meet the...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract, valued at $24,946.00, is for a "Service Plan on a Fluorescent Imaging Plate Reader." The contract has no set-aside designation. Molecular Devices LLC is a for-profit limited liability company that specializes in providing high-performance bioanalytical measurement solutions, including sophisticated laboratory...
- This firm-fixed-price purchase order was awarded by the U.S. Department of Defense's Medical Command (MEDCOM) to Molecular Devices LLC, a subsidiary of Danaher Corporation, for an ImageXpress Pico EC System with Cell Reporter Xpress automated image acquisition and analysis software. The $78,440 contract provides a perpetual software license allowing five concurrent users and analysis on up to ten computer cores. The system delivers standard image analysis algorithms for cell counting, scoring,...